Bayer CEO Werner Baumann says company is 'putting major litigation behind us' while highlighting Q2 growth
Bayer CEO Werner Baumann highlighted “strong operational performance” on Thursday while raising the full-year guidance. But before diving into the details, he summarized Bayer’s plan to settle a slate of ongoing litigation.
“We are making good progress in putting major litigation behind us,” Baumann said on a Q2 call with investors and analysts.
He added that the company is “confident in the litigation strategy” when it comes to glyphosate, the active ingredient in the weedkiller Roundup. Bayer has faced multiple cases alleging that Roundup caused cancer, and recently announced a five-point plan to “a clear path to closure of the U.S. glyphosate litigation.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.